Supernus Pharmaceuticals

+$0.77 (+2.47%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SUPN and other stocks, options, and ETFs commission-free!

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO
Jack A. Khattar, MBA
Employees
563
Headquarters
Rockville, Maryland
Founded
2005

SUPN Key Statistics

Market Cap
1.69B
Price-Earnings Ratio
15.09
Dividend Yield
—
Average Volume
419.39K
High Today
$32.10
Low Today
$31.31
Open Price
$31.47
Volume
581.13K
52 Week High
$32.31
52 Week Low
$17.20

SUPN Earnings

$0.00
$0.25
$0.49
$0.74
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure